The Safety Profile of Upadacitinib in Japanese Patients with Rheumatoid Arthritis

被引：0

作者：

Yamaoka, Kunihiro ^{[1
]}

Tanaka, Yoshiya ^{[2
]}

Kameda, Hideto ^{[3
]}

Hendrickson, Barbara ^{[4
]}

Meerwein, Sebastian ^{[5
]}

Zhang, Ying ^{[4
]}

Takeuchi, Tsutomu ^{[6
]}

机构：

[1] Kitasato Univ, Sch Med, Sagamihara, Kanagawa, Japan

[2] Univ Occupat & Environm Hlth Japan, Kitakyushu, Fukuoka, Japan

[3] Toho Univ, Tokyo, Japan

[4] AbbVie Inc, N Chicago, IL USA

[5] AbbVie GmbH Co KG, Ludwigshafen, Germany

[6] Keio Univ, Sch Med, Tokyo, Japan

来源：

ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2407

引用

页数：3

共 50 条

[1] The Safety Profile of Upadacitinib in Patients with Rheumatoid Arthritis in Japan
Yamaoka, Kunihiro
Tanaka, Yoshiya
Kameda, Hideto
Khan, Nasser
Sasaki, Nobuhito
Harigai, Masayoshi
Song, Yanna
Zhang, Ying
Takeuchi, Tsutomu
DRUG SAFETY, 2021, 44 (06) : 711 - 722
[2] The Safety Profile of Upadacitinib in Patients with Rheumatoid Arthritis in Japan
Kunihiro Yamaoka
Yoshiya Tanaka
Hideto Kameda
Nasser Khan
Nobuhito Sasaki
Masayoshi Harigai
Yanna Song
Ying Zhang
Tsutomu Takeuchi
Drug Safety, 2021, 44 : 711 - 722
[3] Upadacitinib: safety profile in rheumatoid arthritis
Reactions Weekly, 2020, 1830 (1) : 11 - 11
[4] Safety Profile of Upadacitinib up to 6.5 Years of Exposure in Patients with Rheumatoid Arthritis
Cohen, S. B.
van Vollenhofen, R.
Curtis, J. R.
Calabrese, L.
Zerbini, C. A. F.
Bessette, L.
Richez, C.
Strenholt, S.
Coombs, D.
Khan, N.
Gara, A.
Burmester, G. R.
SWISS MEDICAL WEEKLY, 2023, 153 : 25S - 25S
[5] Safety Profile of Upadacitinib up to 3 Years of Exposure in Patients with Rheumatoid Arthritis
Cohen, Stanley
Van Vollenhoven, Ronald F.
Curtis, Jeffrey
Calabrese, Leonard
Zerbini, Cristiano A. F.
Tanaka, Yoshiya
Bessette, Louis
Schlacher, Casey
Shaw, Tim
Liu, John
Enejosa, Jeffrey
Song, Yanna
Burmester, Gerd
ARTHRITIS & RHEUMATOLOGY, 2020, 72
[6] SAFETY PROFILE OF UPADACITINIB UP TO 3 YEARS OF EXPOSURE IN PATIENTS WITH RHEUMATOID ARTHRITIS
Cohen, S. B.
Van Vollenhoven, R.
Curtis, J. R.
Calabrese, L.
Zerbini, C.
Tanaka, Y.
Bessette, L.
Schlacher, C.
Shaw, T.
Liu, J.
Enejosa, J. J.
Song, Y.
Burmester, G. R.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 315 - 316
[7] SAFETY PROFILE OF UPADACITINIB UP TO 6.5 YEARS OF EXPOSURE IN PATIENTS WITH RHEUMATOID ARTHRITIS
Cohen, S. B.
Van Vollenhoven, R.
Curtis, J.
Calabrese, L.
Zerbini, C.
Tanaka, Y.
Bessette, L.
Richez, C.
Strengholt, S.
Coombs, D.
Khan, N.
Gara, A.
Burmester, G. R.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 709 - 710
[8] INTEGRATED SAFETY PROFILE OF UPADACITINIB WITH UP TO 4.5 YEARS OF EXPOSURE IN PATIENTS WITH RHEUMATOID ARTHRITIS
Cohen, S. B.
Van Vollenhoven, R.
Curtis, J. R.
Calabrese, L.
Zerbini, C.
Tanaka, Y.
Bessette, L.
Richez, C.
Lagunes-Galindo, I.
Liu, J.
Camp, H.
Song, Y.
Anyanwu, S.
Burmester, G. R.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 328 - 329
[9] INTEGRATED SAFETY PROFILE OF UPADACITINIB WITH UP TO 4.5 YEARS OF EXPOSURE IN PATIENTS WITH RHEUMATOID ARTHRITIS
Cohen, Stanley B.
van Vollenhoven, Ronald
Curtis, Jeffrey R.
Calabrese, Leonard
Zerbini, Cristiano A. F.
Tanaka, Yoshiya
Bessette, Louis
Richez, Christophe
Lagunes-Galindo, Ivan
Liu, Jianzhong
Camp, Heidi S.
Song, Yanna
Anyanwu, Samuel I.
Burmester, Gerd R.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 : S105 - S105
[10] LONG-TERM SAFETY PROFILE OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, OR ANKYLOSING SPONDYLITIS
Nash, Peter
Burmester, Gerd R.
Cohen, Stanley B.
Winthrop, Kevin
Rubbert-Roth, Andrea
Deodhar, Atul
Elkayam, Ori
Mysler, Eduardo
Tanaka, Yoshiya
Liu, Jianzhong
Lacerda, Ana P.
Pierre-Louis, Bosny J.
Shaw, Tim
Mease, Philip J.
INTERNAL MEDICINE JOURNAL, 2022, 52 : 27 - 27

← 1 2 3 4 5 →